Mirum Pharamceuticals (MIRM) PT Raised to $44 at Baird
Tweet
Share
E-mailGet Alerts MIRM Hot Sheet
Price: $87.96 -1.94%
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 53
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 53
Join SI Premium – FREE
Baird analyst Brian Skorney raised the price target on Mirum Pharamceuticals (NASDAQ: MIRM) to $44.00 (from $39.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Irenic Capital opposes Independence Realty's Centerspace deal - Bloomberg
- Anthropic Fy25 Gaap Net Loss Expands To $41.97 Bln Vs $8.31 Bln In Fy24, Prospectus Shows - Reuters
- Vertical Research Partners Reinstates SPX Technologies (SPXC) at Buy
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Robert W Baird, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
